Skip to main content
Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
17.03
+0.11 (0.65%)
At close: Dec 20, 2024, 4:00 PM
17.01
-0.02 (-0.12%)
After-hours: Dec 20, 2024, 7:24 PM EST

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $388.00K in the quarter ending September 30, 2024, with 4,750.00% growth. This brings the company's revenue in the last twelve months to $651.00K, up 8,037.50% year-over-year. In the year 2023, Keros Therapeutics had annual revenue of $151.00K.

Revenue (ttm)
$651.00K
Revenue Growth
+8,037.50%
P/S Ratio
n/a
Revenue / Employee
$4,787
Employees
136
Market Cap
689.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023151.00K--
Dec 31, 2022---
Dec 31, 202120.10M--
Dec 31, 2020---
Dec 31, 201910.00M--
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orthofix Medical 784.25M
Evolus 248.33M
Axogen 180.86M
IRADIMED CORPORATION 71.31M
CureVac 70.57M
Dianthus Therapeutics 5.37M
Revenue Rankings

KROS News

More News